Germany· DE-A57-a0294b36699010c3
Tigecyclin Cipla
A tigecycline product containing tigecycline, registered in Germany by Cipla Europe Nv. The same ATC class is registered in 17 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Tigecycline is registered in 17 of 19 countries.
Countries holding a registration under ATC J01AA12 (tigecycline), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Tigecycline · ATC J01AA12
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tigecycline costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tigecycline · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- FI Finland$3.05
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Tigecycline
- Manufacturer
- Cipla Europe Nv
- Country
- Germany (DE)
- ATC code
- J01AA12
- ATC class
- Tigecycline
- Defined daily dose
- 0.1 g, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for tigecycline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tigecycline · interactions on record
65 records
- 3 severe
- 13 moderate
- 24 info
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Sodium picosulfateA06AB08moderate
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tigecycline in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTIGECYCLINE ACCORDAccord Healthcare S.L.U., Barcelona
- SpainTIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- United StatesTigecyclineMeitheal Pharmaceuticals Inc.
- PolandTigecycline AccordAccord Healthcare S.L.U.
- United KingdomTigecycline 50mg powder for solution for infusion vialsPanpharma UK Ltd
- FinlandTigecycline AccordAccord Healthcare S.L.U.
- SwedenTigecycline Accord 50 mg Pulver till infusionsvätska, lösningAccord Healthcare S.L.U.
- NetherlandsTigecycline Accord 50 mg, poeder voor oplossing voor infusieAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Tigecyclin Aptapharma, Tigecyclin Hikma
- Bulgaria · Тигециклин Аптафарма, Тигециклин Ромфарм
- Cyprus · Tigecycline Aptapharma, Tigecycline Sapiens
- Czechia · Tigecycline Aptapharma, Tigecycline Mylan
- Denmark · Tigecycline Eql Pharma
- Estonia · Tigecycline Inteli, Tigecycline Norameda
- Spain · Tigeciclina Cipla, Tigeciclina Hikma
- Finland · Tigecycline Eql Pharma, Tigecycline Norameda
- France · Tigecycline Amarox, Tigecycline Hikma
- United Kingdom (Northern Ireland) · Tigecycline Aft Pharma Uk, Tigecycline Amarox
- Greece · Digazor, Tigecycline Anfarm
- Croatia · Tigeciklin Aptapharma, Tigeciklin Galenika
- Hungary · Tigeciklin Galenika, Tigeciklin Noridem
- Ireland · Tigecycline Noridem Enterprises
- Iceland · Tigecycline Accord, Tygacil
- Italy · Tigeciclina Amarox, Tigeciclina Cipla
- Liechtenstein · Tigecycline Accord, Tygacil
- Lithuania · Tigecycline Inteli, Tigecycline Norameda
- Latvia · Tigecycline Inteli, Tigecycline Norameda
- Malta · Tigecycline Anfarm, Tigecycline Aptapharma
- Netherlands · Tigecycline Amarox, Tigecycline Hikma
- Norway · Tigecycline Accord, Tigecycline Eql Pharma
- Poland · Tigecycline Aptapharma, Tigecycline Norameda
- Portugal · Tigeciclina Cipla, Tigeciclina Hikma
- Romania · Tigeciclină Aptapharma, Tigeciclina Atb
- Sweden · Tigecycline Eql Pharma, Tigecycline Viatris
- Slovenia · Tigeciklin Aptapharma, Tigeciklin Diagonalis
- Slovakia · Tigecycline Aptapharma, Tigecycline Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/daf68381-a781-4efc-89d9-b621cece624e GET /v1/drugs/daf68381-a781-4efc-89d9-b621cece624e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Tigecycline",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about tigecycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.